The potential of transdermal nitric oxide treatment for diabetic peripheral neuropathy and diabetic foot ulcers

The Center for Disease Control (CDC) estimates that 29 million Americans have diabetes, and 70% of diabetic patients develop diabetic peripheral neuropathy [1,2]. Up to 27% of the direct medical cost of diabetes may be attributed to DPN [3]. A 2013 article from the American Diabetes Association repo...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes & metabolic syndrome clinical research & reviews 2019-09, Vol.13 (5), p.3053-3056
Hauptverfasser:	Walton, David M, Minton, Stephen D, Cook, Alonzo D
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Cutaneous Diabetes Mellitus - physiopathology Diabetic Foot - drug therapy Diabetic Foot - epidemiology Diabetic Neuropathies - drug therapy Diabetic Neuropathies - epidemiology Humans Neurotransmitter Agents - administration & dosage Nitric Oxide - administration & dosage Prognosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!